Back to Ovarian Cancer
This trial is complete. It is no longer accepting participants. Results may be available on ClinicalTrials.gov.

NCT03571841

NCT03571841
Completed Not Applicable

Who may be able to join

Who might be able to join this trial:

  • You are a woman who has had breast cancer and are currently taking medication to suppress your ovaries' hormone production
  • You are 50 years old or younger
  • You have not had any active cancer treatment in the last 6 months and do not have any cancer treatment planned for the future
  • You are experiencing at least one symptom related to your sexual health (confirm with trial site for the specific symptoms that qualify)
  • You speak English

Who may not be able to join:

  • You have previously had radiation therapy to your pelvic area
  • You have already taken part in a sexual health workshop run by Dr. Bober

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

Trial details

Status
Completed
Phase
Not Applicable
Sponsor
Dana-Farber Cancer Institute
Registry
clinicaltrials_gov
Start date
1 December 2018
Est. completion
1 December 2019

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Change in Sexual Function (FSFI)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 30 June 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

View original record on ClinicalTrials.gov